{"version":"1.0","type":"link","title":"Kras G12C- and G12D-driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models.","author_name":"Huang HC 외","author_url":"https://prs-insight.online/author/Huang%20HC","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97511","thumbnail_width":1200,"thumbnail_height":630}